Table 2.
| Characteristics | HBV+ (n=20) No. (%) |
HBV- (n=41) No. (%) |
p value | HCV+ (n=7) No. (%) |
HCV- (n=54) No. (%) |
p value |
|---|---|---|---|---|---|---|
| Sex | ||||||
| Male | 15 (75) | 28 (68) | 0.59 | 5 (71) | 38 (70) | 0.95 |
| Female | 5 (25) | 13 (32) | 2 (29) | 16 (30) | ||
| Age | ||||||
| <60 | 13 (65) | 23 (56) | 0.51 | 3 (43) | 33 (61) | 0.36 |
| ≥60 | 7 (35) | 18 (44) | 4 (57) | 21 (39) | ||
| Race3 | ||||||
| White | 0 --- | 10 (24) | 0.04 | 1 (14) | 9 (17) | 0.16 |
| Asian/Pacific Islander | 20 (100) | 31 (76) | 6 (86) | 45 (83) | ||
| Birthplace4 | ||||||
| U.S. | 15 (79) | 11 (33) | 0.002 | 3 (50) | 23 (50) | 1.00 |
| Asia and Pacific Island | 4 (21) | 22 (67) | 3 (50) | 23 (50) | ||
| Diagnosis year | ||||||
| 1990–1999 | 7 (35) | 15 (37) | 0.90 | 0 -- | 22 (41) | 0.03 |
| 2000–2010 | 13 (65) | 26 (63) | 7 (100) | 32 (59) | ||
| Stage | ||||||
| Localized | 14 (70) | 29 (71) | 0.87 | 4 (57) | 39 (72) | 0.21 |
| Regional/Distant | 5 (25) | 11 (27) | 2 (29) | 14 (26) | ||
| Unstaged/Unknown | 1 (5) | 1 (2) | 1 (14) | 1 (2) | ||
| Cirrhosis5 | ||||||
| No | 6 (35) | 16 (43) | 0.58 | 2 (29) | 20 (43) | 0.48 |
| Yes | 11 (65) | 21 (57) | 5 (71) | 27 (57) | ||
| First course of treatment | ||||||
| Surgery6 | 17 (85) | 31 (76) | 0.40 | 6 (86) | 42 (78) | 0.63 |
| Other/none | 3 (15) | 10 (24) | 1 (14) | 12 (22) |
1
Based on the detection of HBV (HBV DNA, HBsAg, and/or HBcAg) in tumor and/or non-tumor liver tissue
2
Based on the detection of HCV RNA in tumor and/or non-tumor liver tissue
3
Excludes race other than white, Asian, and Pacific Islander
4
Excludes birthplace other than U.S., Asia, and Pacific Islands; U.S. includes U.S. mainland and Hawaii only
5
Excludes 7 cases with no information on cirrhosis
6
Surgical resection or transplantation